227 related articles for article (PubMed ID: 15934103)
1. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G
Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103
[TBL] [Abstract][Full Text] [Related]
2. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
[TBL] [Abstract][Full Text] [Related]
3. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
[TBL] [Abstract][Full Text] [Related]
5. [Systemic lupus erythematosus: valvular regurgitation and its relation to anticardiolipin antibodies].
Díaz RA; Athanassopoulos G; Nihoyannopoulos P
Rev Med Chil; 1993 Feb; 121(2):156-61. PubMed ID: 8303111
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.
Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA
Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
[TBL] [Abstract][Full Text] [Related]
8. [Echocardiographic changes and anticardiolipin antibodies in patients with systemic lupus erythematosus].
Zhang SD; Wu M; Chen F; Zuo XX; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):692-5. PubMed ID: 17062932
[TBL] [Abstract][Full Text] [Related]
9. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
11. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.
Roldan CA; Shively BK; Crawford MH
N Engl J Med; 1996 Nov; 335(19):1424-30. PubMed ID: 8875919
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
13. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.
Leung WH; Wong KL; Lau CP; Wong CK; Liu HW
Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029
[TBL] [Abstract][Full Text] [Related]
14. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.
Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A
Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
[TBL] [Abstract][Full Text] [Related]
16. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac abnormalities in systemic lupus erythematosus and their association with antiphospholipid antibodies].
Laganà B
Recenti Prog Med; 1993 Oct; 84(10):662-72. PubMed ID: 8235032
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies.
Roldan CA; Shively BK; Lau CC; Gurule FT; Smith EA; Crawford MH
J Am Coll Cardiol; 1992 Nov; 20(5):1127-34. PubMed ID: 1341885
[TBL] [Abstract][Full Text] [Related]
19. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
[TBL] [Abstract][Full Text] [Related]
20. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.
Leszczyński P; Straburzyńska-Migaj E; Korczowska I; Łacki JK; Mackiewicz S
Clin Rheumatol; 2003 Dec; 22(6):405-8. PubMed ID: 14677016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
